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ABSTRACT 
Background 
South Africa has experienced an HIV epidemic that resulted in an increased 
population mortality rate and decreased life expectancy. Since 2007 these trends 
have reversed. Antiretroviral therapy has been shown to decrease mortality and 
increase life expectancy at a community and population level. The impact of 
antiretroviral therapy at a large healthcare facility level is unclear. Mortality 
patterns in South Africa are also changing however the method of data collection 
often underrepresents the burden of HIV. 
 
 
 
Aim 
 To determine the mortality patterns of medical inpatients at CHBAH and to assess 
if improved access to antiretroviral therapy has decreased mortality and increased 
age at death over the period 2006 to 2009 when there was a rapid scale-up of 
antiretroviral therapy in the public sector. 
Methods 
This is a retrospective, cross-sectional study.  Adult mortalities in the medical 
wards were reviewed between 2006 and 2009. Causes of death were ascertained 
by medical consultants who reviewed the patient records and results at the time of 
completing patient death certificates.. The annual mortality rates were determined 
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and deaths were analysed with respect to age at death, sex and HIV-status. 
Results 
Data on 16020 deaths were available for analyses. The overall crude mortality rate 
fell significantly year on year from 113/100000 to 79/100000. The mean age at 
death for HIV-negative patients was 60in 2006 and showed no significant increase 
over the study period. The mean age at death of HIV-positive patients  increased 
significantly year on year from 38 in 2006 to 40 years in 2009 . 
The peak age category of death for HIV-positive females moved from 30-34 to 35-
39 years over the study period. Peak age category at time of death in males 
remained unchanged at 40-49 years An estimated total of 101478  years of life 
were lost to HIV disease in females and 65008 years were lost in HIV-positive 
males during the study period . HIV, tuberculosis and pneumonia were the top 
three causes of death and their proportional contribution to mortality remained 
unchanged over the study period. Diseased associated with advanced 
immunosuppression such as cryptococcal meningitis and infectious diarrhoea 
decreased over the study period. 
The mortality trends seen in this study are similar to those reported at population 
level. Increases in life expectancy occurred in the HIV-positive population and   
opportunistic infections as major contributors to death decreased, during the time 
that antiretroviral therapy was being escalated. 
Conclusion 
Improvement in mortality patterns within the HIV-positive group at the time that 
antiretroviral therapy was escalated suggest that cART roll-out had a positive 
impact on mortality at CHBAH. 
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1.0 INTRODUCTION 
A country’s mortality trends  accurately reflect its developmental level. In 
2005, a person born in northern, southern or western Europe could expect 
to live for an average of 78.6 years.1  
 
Mortality rates have decreased worldwide over the past twenty years while 
during the same two decades the mortality rates in South Africa increased.2  
The increasing mortality rates seen in South Africa can be attributed to the 
delayed response of the South African Health system to the HIV epidemic 
in the region.  
 A quarter of all HIV-infected persons in sub-Saharan Africa live in South 
Africa. South Africa has  the highest number of people living with HIV and 
Acquired Immunodefiecy Syndrome (AIDS) in the world, estimated at 6.2 
million individuals. 1,2,3,4 
 
As a result of HIV,  the expected lifespan of a South African was reduced by 
an estimated 13 years from 64 years in 1990 to 51 years in 2005.5 It was 
estimated that during this time period around one thousand people were 
dying daily in South Africa due to HIV-related disease.6 
  
Historically, low income countries have distinct disease profiles 
characterised by high child mortality, widespread malnutrition and a 
dominance of communicable disease.  This typical mortality pattern evolves 
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as development progresses and changes to a predominance of 
noncommunicable diseases.7 
During the transition developing countries suffer a double burden of disease 
due to the occurrence of both communicable and non-communicable 
disease profiles simultaneously, in South Africa the high toll of unnatural, 
trauma-related deaths and the HIV epidemic resulted in a quadruple 
disease burden.7  This quadruple burden means mortality rates in South 
Africa far exceed those of countries with a similar gross domestic product 
and  health expenditure profiles.8 
 
Of the 57 million global deaths reported by the World Health Organisation 
(WHO) in 2008, 36 million were due to non-communicable diseases with 
ischaemic heart disease and cerebrovascular disease cited as the leading 
causes of death in this category in 2004. The highest ranking 
communicable disease was respiratory tract infections. Globally, HIV/AIDS 
ranked as the sixth leading cause of death.9 
 
In contrast to this, Bradshaw et al found AIDS- related illnesses emerged as 
the overwhelming number one cause of premature mortality in all nine 
provinces of South Africa during the same time period.7 
After HIV/AIDS- related disease, the top twelve causes of years of life lost 
for South Africans  in descending order were homicide and violence, 
tuberculosis, diarrhoeal diseases, road traffic accidents, lower respiratory 
tract infections, cerebrovascular events, ischaemic heart disease, 
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hypertensive heart disease, suicide, septicaemia and complications of 
diabetes mellitus.7 
In 2008 it was estimated that 79% of years of life lost were due to 
communicable diseases with only 15% being attributed to non-
communicable diseases. Despite marked economic differences between 
the nine provinces of South Africa the death rate due to non-communicable 
diseases was similar.7 
AIDS-related illness accounted for 14% of total years of life lost  in the 
Western Cape at the low end to  51% of total years of life lost in KwaZulu-
Natal, reflecting the distribution of HIV in South Africa.7  In 2012 the Human 
Sciences Research Council household survey found that only just over a 
third of HIV infected adults knew their HIV-status.10  
According to the WHO South African health profile, the prevalence of HIV in 
2009 was 178 per 1000 adults aged 15- 49 years, with a global average of 
eight persons per 1000.11 
In 2002-2005 the HIV incidence among women, especially young women 
aged 15- 24 years was ten times higher than their male counterparts. 
During the period 2005- 2008, a lower HIV incidence rate of 1.3/100 p.a. 
was estimated for both men and women aged 15-49 years.4 
 
There was a statistically significant decline in incidence of HIV infection 
among young women between the ages of 15 and 24 years, but overall 
population incidence did not decrease.4 
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In the age group 25- 49 years the incidence among both men and women in 
2005-2008 were similar to the estimated incidence for the 2002-2005 
period.4 
 
Without therapeutic intervention the majority of individuals living with 
HIV/AIDS face certain death, Bradi et al (2006) showed that without 
combination  antiretroviral therapy (cART) 22.2% of patients with WHO 
stage IV disease will die within six months of diagnosis.12 
 
Mortality statistics and related information on death occurrences between 
1997 and 2013 was released in the first quarter of 2014 by Statistics South 
Africa.13 This information was based on death reports collected through the 
South African civil registration system which is maintained by the 
Department of Home Affairs. The report outlined observed trends over the 
fifteen year period. Maternal and perinatal deaths were included but 
stillbirths were excluded from the report. 
The number of natural deaths steadily increased from 1997 and peaked in 
2006 with 560415 deaths for all ages then declined from 2007 to 2011 with 
467531 deaths reported in 2011and further declined to 411714 in 2013.13 
The highest percentage of deaths in 2011 occurred amongst age group 35- 
39 years (7.8%) followed by the age group 30-34 years (7.3%). The 
percentage of deaths in the 30-34 year age group declined from 9.5% in 
2007 to 7.3% in 2011.13 
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It was noted that the trend in the age pattern of deaths showed increases in 
the proportion of deaths occurring in older age groups and decreases in 
younger age groups, death distributions by sex and year of death from 1997 
to 2011 showed the proportion of male deaths were consistently higher than 
female deaths. Between 2006 and 2011 the proportion of female deaths 
decreased from 49.3% to 48.3%.99  
Male deaths were the highest in the age group 35-39 years (8.4% of all 
male deaths) and female deaths peaked at 30-34 years (7.2%) Notably the 
differences between deaths in males and females were minimal at younger 
ages (0-24 years).99 
Non-communicable diseases of the circulatory system causing death 
increased from 14.7% in 2009 to just over 16.0% in 2011 and 
cerebrovascular diseases was noted as the leading cause of death in 
persons older than 65 years followed by unspecified other forms of heart 
disease. Tuberculosis was ranked at number eight in this elderly population 
group.99 
Most deaths were reported by health care facilities (46.3%) followed by 
deaths that occurred at home (26.0%) reported by family members.99 
cART became available in public clinics on the 1st  April 2004, prior to this, 
access to cART was limited to a few patients on clinical trials and those with 
financial means to fund their own treatment. All cause mortality in South 
Africa increased by 79% between 1997 and 2004, this increase was mainly 
due to natural causes.14 
6 
 
Despite the introduction of state funded antiretroviral therapy in 2004, 
national rollout was hesitant at the outset and aggressive widespread 
initiation and escalation only started in late 2007 with increased political will 
and international funding. The landmark National HIV&AIDS and STI 
Strategic Plan 2007–2011 began to address the monumental challenge. 
The two primary goals of the HIV/AIDS and STI Strategic plan were to 
reduce the HIV incidence rate by 50% and to expand the access to cART to 
include 80% of newly ART-eligible persons by 2011.15  
 
South Africa’s cART roll-out programme resulted in  a rapid increase in the 
number of HIV-infected patients on antiretroviral therapy.In mid-2005 a total 
of 60 600 public sector patients were receiving cART , by July 2009 this 
number had  increased to 748 000.16 A 2012 South African National HIV 
Survey reported that 2 002 350 patients were on cART with 6.4 million 
persons living with HIV/AIDS at the time.10  
 
The vast majority (85%) of these patients received treatment through the 
public healthcare sector. Just over 10% were treated within disease 
management programmes in the private sector with the remaining four 
percent of patients cared for by NGO's managing community treatment 
programmes.10 
 
 Around 61% of all who benefitted from cART were women with men 
accounting for a third of patients and children 8% of those with sustained 
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access to cART. Gauteng and KwaZulu Natal provided care to more than 
56% of all patients receiving antiretroviral therapy.16 
 
The question of cART efficacy in the South African context has been 
answered as multiple observational studies have clearly shown that cART is 
as effective in resource- restricted communities as it is in developed 
countries.17 
Yet despite the advances made in the era of cART and the considerable 
decline in the incidence of AIDS- defining illnesses among persons living 
with HIV, these patients still continue to have excess mortality compared 
with the general population in the same age and sex groups.18 
 
 The possible causes for the noted excess mortality was  investigated by  
Wong et al(2012) at the Charlotte Maxeke Johannesburg Academic 
Hospital (CMJAH) during the period  January to December 2009  in which 
39 HIV-reactive adult patients on cART who died during admission to 
CMJAH were enrolled in a prospective post- mortem study.19 
 
The study showed that tuberculosis  was the leading cause of death in both 
the study (76%) and control (57%) groups of patients. Tuberculosis was 
diagnosed microbiologically or histologically in 30% of deceased patients 
with no clinical findings suggestive of mycobacterial infection. The high 
incidence of unsuspected tuberculosis in this study suggests tuberculosis 
may be an under reported major cause of death in this population.19  
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In the recent 2014 Statistics South Africa report, infectious diseases were 
cited as the main cause of death from 2009 to 2011 with 25% of deaths in 
2009 attributed to this main group of causes. A steady decline in deaths 
from Infectious diseases was noted over the three year period with just over 
23% reported in 2011.13 
Tuberculosis was cited as the leading cause of death for persons between 
15 and 49 years. This is not surprising as South Africa carries an enormous 
burden of tuberculosis-infections. Among the 22 countries with the highest 
burden of TB (81% of all TB cases globally) South Africa has the highest 
incidence and prevalence of tuberculosis after adjusting for population 
size.20 South Africa has the second highest number of patients diagnosed 
with multidrug-resistant TB cases and the largest number of HIV-associated 
TB cases globally.21  The incidence of tuberculosis was 300 per 100 000 
people in the early 1990’s to more than 600 cases per 100 000 people in 
early 2000 and more than 860 per 100 000 people in 2013.20 
HIV-disease was noted as the third leading cause of death (6.6%) for 
persons between 24- 49 years and this was the only age group where HIV 
–disease was among the top ten underlying causes of death according to 
Statistics South Africa.99 
 
 
The finding by Wong et al that tuberculosis contributed to the majority of 
deaths correlates with studies from India and Sub-Saharan Africa.19  
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In India, Mumbai, tuberculosis was named as the chief cause of death in 
63% of HIV- infected but  antiretroviral -naive  persons  in a series of 236 
patients22  and furthermore in a 2010 meta-analysis of post-mortem studies 
of HIV-reactive adults in Sub-Saharan Africa over the past twenty years, 
tuberculosis was considered the number one cause of death in 45% of 
adults.19 
The study by Wong et al (2012) found that in those who died, Immune 
Reconstitution and Inflammatory Syndrome (IRIS) was an important 
contributing factor  in the deaths  of  74% (11/15) of patients initiated early 
on antiretroviral therapy.19  
 Ingle et al (2010)  assessed the differences in access and subsequent 
patient outcomes across antiretroviral  treatment clinics in the Free State, 
South Africa,  found that a significant number of  the sickest patients in their 
cohort died before cART could be initiated.  Of all deaths over the four year 
study period, 83% occurred in eligible patients  not receiving cART.23 In 
those who received antiretroviral therapy  the mortality ranged from 8.1% to 
32.8% 
A study by Herbst et al (2009) conducted in rural KwaZulu-Natal  showed 
that the widespread roll-out of cART significantly impacted on the adult 
population mortality in a secluded community with both a high prevalence of 
HIV infection and an equally high mortality rate related to HIV with a 
subsequent significant mortality rate reduction of 22% in females and 29% 
in males in the study population.24 
Mortality from tuberculosis in pregnant women has also been shown to 
decrease with improved cART coverage in both KwaZulu Natal and the city 
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of Johannesburg (Personal correspondence A Black 2014).25  The roll-out of 
antiretroviral therapy can be expected to result in a decline in mortality rates 
throughout sub-Saharan Africa.  
A report from the Soweto area suggested a high incidence of both HIV-
disease and HIV-treatment related mortality.27 
Studies from South Africa and Cambodia have shown that improved cART 
coverage decreases mortality from infectious diseases and TB in 
particular28,29  Improved antiretroviral therapy coverage has also been 
shown to increase the mean age at time of death. HIV-positive adults in 
South Africa have near normal life expectancy provided that they start ART 
before their CD4 count drops below 200 cells per cubic millimeter.30 cART 
coverage has been reported to have increased in adults 21.5% in 2006 to 
68.2% in 2009 in Gauteng provence.31 
 
The Statistics South Africa Data is derived from Death Notification forms 
(DHA 1663 or BI-1663) the accuracy of the cause of death reported on 
these forms has been shown to be poor.  The inclusion of HIV related 
causes of death is often misclassified due to reasons beyond poor quality 
such as concerns around confidentiality and possible litigation by the family 
of the deceased. REF Nojilana and Birnbaum J 
The Statistics South Africa data is population based and no large facility 
data was found to see if inpatient hospital mortality patterns were reflective 
of the available population data.  
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No published reports to date have reviewed the impact of the cART scaling-
up process on the adult medical patient mortality patterns in the Soweto 
area which consists of a large urban population whose health needs are 
largely served by a single 2700 bed university- supported hospital, the Chris 
Hani Baragwanath Academic Hospital (CHBAH) which also maintains a 
confidential mortality data base with cause of death collected independent 
of the official Death notification forms. 
1.1 AIM OF THE STUDY 
 
The aims of this study are to describe the mortality patterns of 
medical inpatients at CHBAH over the time period 2006 to 2009 and  
to assess if escalated  access to antiretroviral therapy  in the Soweto 
community has altered mortality patterns over this period. 
 
 
1.2  OBJECTIVES 
 
a. To describe the demographics of deaths of medical in- 
patients who died at CHBAH during the period  2006 to 2009.  
 
b. To identify the diagnoses responsible for more than 75% of 
deaths of medical in- patients who died at CHBAH during the 
period  2006 to 2009. 
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c. To determine if there is any association between HIV status, 
sex, age of death and infectious versus non-infectious cause 
of death. 
 
d. To determine if any changes in the pattern of mortality 
regarding age and sex of deceased occurred during the 
period of intensified roll-out of antiretroviral therapy. 
 
 
2.0 METHODS 
 
2.1 Study design 
 
This is a retrospective, cross sectional study with descriptive and 
comparative analysis. 
 
2.2 Study population 
 
The population of Soweto in 2005 comprised of approximately 1.12 
million predominantly black urban South Africans. CHBAH is a public 
hospital that serves approximately ninety percent of Sowetan 
residents, with the remaining 10% using private healthcare. CHBAH 
is a large facility with 2700 beds. Although CHBAH is an Academic 
hospital it caters for all levels of patients requiring hospitalisation 
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from the Soweto area, and at the time of the study was the only 
public inpatient facility for the area. 
The reported prevalence of HIV in Gauteng between 2005 and 2009 
was 24.9 % in adults.31 cART coverage in adults has been reported 
to have increased from 21.5% in 2005 to 68.2% in 2009.16  
The earliest available HIV roll-out programme data for the Soweto 
area is from 2008, when it was reported that a cumulative 15 373 
persons had been started on cART and  by 2010 this number had 
increased to a cumulative 74 864 persons. The National Department 
of Health District Health information system reported 563 508 
patients remained on cART at the end of 2013 in the Soweto area 
(City of Johannesburg, Region D).32 
 
 
2.3 Data collection 
 
In 2006 in order to enable monitoring of deaths at CHBAH a data 
sheet was developed to serve as a paper based mortality tool. The 
data form is completed by a medical consultant at the time of signing 
the patients’ death certificate. Cause of death is ascertained by the 
medical consultant by reviewing the patient file, cause of death 
reported on the sheet need not be the same as that reported on the 
death certificate (due to stigma surrounding HIV- status this and HIV-
related diseases are not always stated on the death certificate which 
is made available to patients families at CHBAH) 
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 HIV status is reported as known positive, known negative, not 
known or clinically suspected because of AIDS-defining illness, 
categorising a patient as clinically suspected HIV infection was at the 
discretion of the consultant and no fixed guidelines were provided for 
this classification.  
If the HIV-status is not available in the patient records a search of the 
hospital laboratory records is done and the data sheet updated by an 
investigator. 
The CD4- cell count reported is the last available result on the 
hospital laboratory system, the vast majority being taken during final 
admission.  Antiretroviral therapy status is determined from patient 
records. 
All death certificates of deceased patients from within the 
Department of Medicine are meant to be signed by a Medical 
Consultant however Medical Registrars may sign death certificates 
after hours if requested to by mortuary staff, in these instances the 
death data collection sheet was not completed. All deaths occurring 
at CHBAH were recorded on a Medicom data base, number of 
deaths reported as having occurred in all of the Medical wards was 
retrieved from the Medicom system to give the closest approximation 
available of the true number of Medical deaths occurring at CHBAH 
during the time period 2006-2009.  
Data management 
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The data was captured into Microsoft Excel 2007 (Microsoft, 
Redmond, WA). Cause of death was coded using the tenth 
International Classification of Diseases codes(ICD-10), by a person 
trained in ICD-10 coding. Where queries arose a consultant assisted 
in assigning the code.  
Primary cause and possible secondary causes of death were coded 
for; only primary cause of death was used for this analysis. 
The number and sex of medical admissions were collected daily from 
the medical admission ward register by Dr A Black and entered into 
a separate medical database for medical admissions. 
Both data bases were started in 2006 as operational data bases 
within the Department of Medicine. The data used for analysis was  
delinked from patient identifiers, and the data sheets were filed in a 
locked filing cabinet within the Department of Medicine. 
  
2.4 Inclusion criteria 
Records of all adults who died in the adult medical wards at CHBAH, 
of a medical cause between 2006 and 2009. 
2.5 Exclusion criteria 
All non-medical deaths including antenatal and perinatal deaths even 
if they died in an adult medical ward. 
2.6 Ethical considerations 
Ethical approval has been granted by The University of the 
Witwatersrand Human Research Ethics Committee. 
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 Clearance number  M111103 (Appendix X) 
            
          2.6      Methodology   
 
Systematic review of the Department of Medicine database 
constructed over the period 2006- 2009. 
Variables captured: 
Age, sex, cause(s) of death, HIV- status, CD4-cell  count, cART 
status. 
 
          2.7    Statistical analysis 
 
Descriptive statistics were presented with 95% confidence intervals, 
standard deviations for means and inter-quartile range for median 
values. Comparisons between discrete data categories were done 
using Chi-square test for large numbers and Fisher’s exact test for 
sparse data.  Crude mortality rates were determined and expressed 
as a rate per 100 000. The total number of medical admissions for 
each year was used as the denominator for the population.  
For comparative statistics, continuous data were analysed using the 
two-tailed unpaired t test. A p-value of <0.05 was considered 
significant.  Two-tailed Pearson’s Correlation  Co-efficient test was 
computed at a 0.01 level of confidence to determine any correlation   
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between HIV-status, sex,  decreased age at death and infectious 
versus non-infectious causes of death. A probability result < 0.05 
was considered significant. While only the primary cause of death 
was included in the analysis, consultants completing the data sheets 
could assign multiple causes of death to a single patient such as 
renal failure and diabetes. As the data collected included other 
contributors to death other than just the primary cause of death a 
principle components analysis using all contributing causes of death 
was done to determine if any contributing factors of death stood out 
as playing a significant role in the mortality of this population. 
For cause of death  conditions listed as the primary cause of death 
falling within the top 75% of causes of death were analysed. Using 
the top 75% of causes allowed for a manageable number of causes 
to be listed and provided more data for analysis than if the report 
was restricted to only the top 10 causes of death..  
.  
 
Statistical package: 
Intercooled STATA version 10 (Stata-Corp, LP, College Station.TX) 
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2 RESULTS 
The department of Medicine data base contained 16020 deaths for the 
review period 2006-2009. These deaths were all captured from the data 
sheets.  The number of Medical deaths recorded in the Hospital Medicom 
data base for the same time period was 22668. 
 
        3.1  
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The number of annual admissions for both Medicom and the Department of Medicine database 
together with the annual number of medical admissions are shown in table 1. Annual crude 
mortality rates with differences between years for both the Medicom and Department of Medicine 
database are included in table 1. The difference the annual number of deaths reported in Medicom 
and those reported in the Department of Medicine database represents possible missing data. 
Table 1 Crude mortality rates by year 
 
 Number of 
admissions 
Number of 
deaths 
Crude mortality 
rates per 100 000 
admissions 
P value for 
difference 
between previous 
year 
2006  Dept Med 
         Medicom 
         Difference          
44055 4997 
5758 
761 (13%) 
113 
131 
 
_ 
2007  Dept Med 
          Medicom 
         Difference 
39079 4303 
6218 
1915 (31%) 
110 
159 
0.13 
<0.05 
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3.3 DEMOGRAPHICS 
 
3.3.1 Age: 
From an initial sample size of 16020, 15800 cases were included in 
the analysis as 220 cases were missing..  
2008  Dept Med 
         Medicom 
        Difference 
38971 3951 
5437 
1486 (27%) 
101 
140 
<0.05 
<0.05 
2009  Dept Med 
         Medicom 
        Difference 
40828 3216 
5255 
2039 (39%) 
79 
130 
<0.05 
<0.05 
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The distribution of age and death appears bimodal and skewed to 
the left, in the histogram shown as graph 4. Testing for normality 
gave a kurtosis value of -0.193. 
 
Graph 4: Age distribution of the sample  
 The statistical test for normality allowed for parametric analysis and the age 
of the entire mortality database is described in table 1 by year. 
 
 
 
 
Table 1: Age description of all deaths by year 2006-2009 
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 2006 2007 2008 2009 
N 4499 4257 3871 3121 
Mean age in 
years 
48.00 48.90 47.82 49.39 
Standard 
deviation 
17.31 17.09 16.80 17.59 
     
95% CI 47.6-48.6 47.9-49.0 47.2-48.3 48.7-50.0 
Range 14-105 14-99 14-99 19-108 
 
Proportion of deaths between the age of 20 and 60 years  is represented by 
graph 5 for the percentage of females and graph 6 for percentage of males.  
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Graph 5: Females, age at time of death by age category expressed 
in percentage on Y-axis from(20-60 years) 2006-2009 
 
 
Graphs 6: Males, age at time of death by age category (20-60 
years) 2006-2009 expressed in percentage contribution. 
 
Age analysis by HIV-status:  
HIV-negative status was significantly corrrelated to Age: r = 0.378; as age 
increase the probability of being HIV-negative increases. HIV-positive 
status was significantly correlated to Age: r = -0.048: as age decreases the 
probability of being HIV-positive increases. 
Sub analysis was done only on patients with confirmed HIV-status. Sample 
size was sufficient to detect a two year difference at α < 0.05 and β > 0.9 for 
all the sub-analysis.     
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The age of death of confirmed HIV-positive patients is described year in 
table 2. 
    
 
Table 2: Age description of confirmed HIV-positive deaths 
 2006 2007 2008 2009 
n 2346 1982 1915 1533 
Median 38.8 38 38 39 
Mean 38 39.1 39.1 40 
Standard 
deviation 
10.2 10.1 10.1 10.8 
     
95% 
Confidence 
Interval 
32.9- 43.0 32.6-43.3 32.6-43.3 35.7-42.2 
Range 16-83 14- 80 14-79 14-91 
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The age of death of confirmed HIV-negative patients is described year in 
table 3. 
 
         .         
Table 3: Age description of confirmed HIV-negative deaths          
 2006 2007 2008 2009 
N 824 620 602 407 
Median 60 63 62 63 
Mean 60 61.6 59.6 61.5 
SD 17.3 16.8 18.0 17.8 
     
95% CI 51.5-68.5 55.1-70.9 52.5-71.4 52.5-70.9 
Range 16-98 17-97 14-99 15-104 
 
 
Table 4: Comparison of difference in mean age at death of HIV-positive 
patients 2006-2009 
 2006-2007 2007-2008 2008-2009 
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Difference in 
means (95% CI) 
1.1(0. 5-1.7) 0.0 (-0.6-0.6) 0.9 (0.2-1.6) 
p < 0.0001  0.01 
 
 
 
Table 5: Comparison of difference in mean age at death of HIV-negative 
patients 2006-2009 
 2006-2007 2007-2008 2008-2009 
Difference in 
means (95%CI) 
1.6 (0.2-3.4) -2.0 (-4.0—0.0) 1.9(0.4-4.2) 
p  0.08 0.05 0.1 
 
 
 
 
Table 6: Mean age at time of death by sex, irrespective of HIV-status. 
 Females Males 
2006 47.5 years 48.7 years 
2007 44.0 years 46.0 years 
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2008 44.5 years 46.4 years 
2009 46.2 years 46.9 years 
 
 
 
 
 
Table 7: Difference in mean age at death between males and females by HIV-   
status 
  Females 
mean age 
(years) 
n Males 
mean 
age 
(years) 
n Difference in 
mean 
(95%CI) 
p 
HIV + 2006 37.2 1272 40.8 1074 3.6(2.8-4.5) <0.05 
2007 37.6 1045 40.8 937 3.2(2.3-4.1) <0.05 
2008 35.9 933 41 922 5.0(4.2-5.8) <0.05 
2009 38.7 788 41.5 751 2.8(1.7-3.8) <0.05 
HIV - 2006 61.8 434 58.0 391 3.81.5-6.2) <0.05 
2007 63.7 337 59.1 283 4.6(2.0-7.2) <0.05 
2008 60.7 302 58.8 295 1.9(-1.0-4.8) 0.21 
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2009 63.9 214 58.8 196 5.1(1.6-8.5) <0.05 
 
 
 
 
 
Table 8: Difference in means of age at time of death of HIV-negative 
females compared to HIV-positive females and difference in mean age at 
death of HIV-negative males compared to HIV-positive males. 
 
 HIV- Females vs  
HIV+ Females 
Difference in mean 
(95%CI) 
HIV - Males vs 
 HIV+ Males  
Difference in mean 
(95%CI) 
2006 ∆24.6(23.2-26.0) 
p<0.0001 
∆17.1(15.818.5) 
p<0.0001 
2007 ∆26.1(24.6-27.7) 
p<0.0001 
∆18.3(16.8-19.9) 
p<0.0001 
2008 ∆24.7(23.2-26.3) 
p<0.0001 
∆17.9(16.3-19.5) 
p<0.0001 
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2009 ∆25.2(23.2-27.1) 
p<0.0001 
∆17.3(15.4-19.2) 
p<0.0001 
 
 
A crude estimate of years of life lost due to HIV infection was made by 
multiplying the difference in age at death between HIV negative and 
HIV positive deaths by the number of HIV positive deaths (Table X) 
Table X  
 HIV-positive females HIV-positive males 
2006 31291 18365 
2007 27274 17147 
2008 23045 16504 
2009 19857 12992 
Total 101478 65008 
 
 
 
 
3.3.2 Sex:  
 
30 
 
While a sample of 16020 was available 178 did not have their sex 
documented.The dataset indicated that 50.8% of the sample was 
female and 48% male. The sex split is consistent with the 
demographics of South Africa according to the Census (2011) report 
for South Africa and falls within their 95% confidence interval, 
suggesting that the sex distribution of my sample of deceased 
patients is similar to the general living population.  
 
HIV status and sex: 
 
   
Graph 8: HIV-status and sex distribution of deceased patients 2006-
2009 
There was no significant difference between HIV-status and sex 
when testing the entire sample, however sub-analysis on confirmed 
HIV status showed significant correlation between female sex and 
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HIV status r=0,03; females were more likely to be HIV positive than 
males (p >0.001)  
 
 
 
 
3.4 HIV- Status: 
The HIV status as classified by the dataset included analysis of HIV- 
positive, HIV- negative, HIV suspected, and HIV unknown.  
HIV- positive: 
From the dataset, 49.5% of the cases were HIV- positive, 15.5% 
were HIV- negative, 7.7% of the cases had suspected HIV, and 
24.4% HIV status unknown. 2.9% of the values indicative of the HIV 
status were missing from the dataset.  
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  Graph 9: HIV-status of deceased patients 2006-2009 
2006: 52.2% of patients  were HIV- positive; 18.4% of patients were 
HIV-negative; 7.8% of patients were suspected of being HIV-
infected; and 21.6% of patients presented with an unknown HIV 
status.  
 
2007: 46.7% of patients were HIV- positive; 14.5% of patients were 
HIV -negative; 8.9% of patients presented being suspected of HIV; 
and 23.6% of patients presented with unknown HIV status. 
 6.3% of the cases in 2007 were invalid. 
 
2008: 49.6% of patients were HIV -positive; 15.5% of patients were 
HIV- negative; 7.3% of patients were suspected of being HIV-positive 
and 23.3% of patients presented with unknown HIV status.  
4.3% of the cases in 2008 were invalid. 
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2009: 49.1% of patients were HIV- positive; 13% of patients were 
HIV- negative; 6.6% of patients were suspected of being HIV-
positive; and 26.4% of patients presented with unknown HIV status. 
4.9% of the cases in 2009 were invalid. 
There was no significant trend for the presentation of HIV- positive 
patients. However, there was a clear decrease in the number of 
patients presenting with a confirmed HIV-negative status over the 
four  year period.  
Unknown HIV- status increased over the four year period.  
 
 
3.5 CD4-count: 
From the dataset, 12050 cases representing 75.2% of the data were 
elegible for a CD4 –count under the South African HIV Guidelines; 
however only 4005  CD4 counts were available for analysis.  
Median CD4-count is 44 cells/mm
3  IQR 16-104 
 
Table 9: CD4 - count and frequency by categories 
CD4 Count Frequency 
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<1  10 
<10  83 
<50   482 
<100   532 
<150  462 
<200  340 
<250  373 
<300  196 
<350  283 
<400  280 
<450  118 
<500  66 
>500  
aggregated 
 780 
 
 
 
3.6 Antiretroviral therapy: 
Table 10: cART-eligibility by CD4 -criteria and cART coverage 
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Number of 
confirmed  
HIV 
positive 
patients 
 
Patients on 
ART at time 
of death 
irrespective 
of CD4-cell 
count 
 
Patients 
eligible for 
cART by CD4 
criteria alone 
not receiving 
treatment 
(CD4<200 
cells/mm
3
) 
2006 2381 226 1101 
2007 2008 238 758 
2008 1961 284 733 
2009 1578 281 556 
  
 
In 2006 of the 2381 HIV-positive confirmed patients 226 received 
ART at time of death (9.49%). The average CD4-count for those on 
cART was 110 cells/mm. A total of 1101 patients (46% of total HIV-
positive patients) with a documented CD4-count of less than 200 
cells/mm3  were not receiving  cART at time of death.  
In 2007 of the 2008 HIV-positive confirmed patients 238 received 
ART at time of death (11.8%). The average CD4-count for those on 
cART was 98 cells/mm. A total of 758 patients (37% of total HIV-
positive patients) with a documented CD4-count of less than 200 
cells/mm3  were not receiving  cART at time of death. 
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In 2008 of the 1961 HIV-positive confirmed patients  284 received 
ART at time of death (14.5%). The average CD4-count for those on 
cART was 102 cells/mm. A total of 857 patients (43% of total HIV-
positive patients) with a documented CD4-count of less than 200 
cells/mm3  were not receiving  cART at time of death. 
In 2009 of the 1578 HIV-positive confirmed patients  281 received 
cART at time of death (17.8%). The average CD4-count for those on 
cART was 106 cells/mm. A total of 556 patients (35% of total HIV-
positive patients) with a documented CD4-count of less than 200 
cells/mm3  were not receiving  cART at time of death. 
The data sheet did not account for timing of ART initiation, we 
therefore are unable to comment on the timing of ART initiation and 
subsequent  death. 
When comparing the period of 2006 and 2007 with the period 2008 
and 2009, the number of cART eligible patients on cART increased 
significantly (p=0.0001)  
The above is limited in that only those patients who were 
documented HIV-positive with known CD4-counts were included in 
the 2-tailed Fischer exact test analysis 
 
3.7 Causes of death:  
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on ranks the top(>75%) primary causes of death. These are 
based on the ICD-10 codes assigned to the causes of death 
recorded on the data sheet 
 Percentage of cause of death represented:  
2006: 78%  
2007: 88.58%  
2008: 84.85%  
2009: 80.89%. 
Table 11: Diagnoses representing >75% causes of death by year 2006-
2009 
 
 2006   2007   2008   2009 
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1 
HIV 
unspecified 
20.6%(n=1028) 
 1 
HIV 
unspecified 
20.9% (n=898) 
 1 
HIV 
unspecified 
21.7% (n=858) 
 1 
HIV 
unspecified 
20.1% 
(n=675) 
2 
Pneumonia 
unspecified 
11.6% (n=582) 
 2 
Pneumonia 
unspecified 
13.2% (n=570) 
 2 
Pneumonia 
unspecified 
13.2% (n=520) 
 2 
Pneumonia 
unspecified 
13.4% 
(n=431) 
3 
PTB confirmed   
6.5% (n=325) 
 3 
Renal failure 
unspecified 
7.1% (n=305) 
 3 
Septicaemia 
7.5% (n=298) 
 3 
Septicaemia 
9.4% (n=302) 
4 
PTB 
unspecified 
6.2% (n=310) 
 4 
Stroke 
unspecified 
6.9% (n=295) 
 4 
PTB confirmed  
7.0% (n=277) 
 4 
Renal failure 
unspecified 
7.9% (n=255) 
5 
Septicaemia 
6.2% (n=310) 
 5 
PTB 
unspecified 
6.8% (n=293) 
 5 
Acute 
gastroenteritis 
6.0% (n=237) 
 5 
PTB 
confirmed  
6.9% (n=222) 
6 
Renal failure 
unspecified 
5.5% (n=276) 
 6 
Septicaemia 
6.8% (n=291) 
 6 
Stroke 
unspecified 
5.2% (n=207) 
 6 
Stroke 
unspecified 
6.1% (n=196)  
7 
Meningitis 
unspecified 
3.8% (n=189) 
 7 
PTB confirmed 
6.5% (n=279) 
 7 
Renal failure 
unspecified 
4.8% (n=190) 
 7 
TB of other 
organs       
4.9% (n=156) 
8 
Hypertension 
3.2% (n=159) 
 8 
Hypertension 
4.2% (n=179) 
 8 
Meningitis 
unspecified 
4.5% (n=177) 
 8 
Hypertension 
4.2% (n=134) 
9 
Acute 
gastroeneritis 
3.0% (n=150) 
 9 
Acute 
gastroenteritis 
3.3% (n=140) 
 9 
PTB 
unspecified 
4.2% (n=167) 
 9 
PTB 
unspecified 
4.0% (n=130) 
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Graph 10 to 13 shows the causes of 75% of deaths with all TB 
aggregated into single category. 
 
 
Graph 10: Causes responsible for >75% of deaths in 2006 
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Graph 11: Causes responsible for >75% of deaths in 2006 
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Graph 12: Causes responsible for >75% of deaths in 2008 
 
 
Graph 13: Causes responsible for >75% of deaths in 2009 
 
As the database included both primary as well as contributory or secondary  
causes of death for each individual patient, a principle components analysis 
(PCA) was conducted at a 0.05 significance level, to determine the loadings of 
numerous causes of death and  to isolate the highest contributing cause to the 
primary listed causes of death from the period 2006-2009. From 2006 to 2009, 
where not reported as the primary cause of death, the only conditions found to 
be significant (p<0.05) contributors to the primary reported causes of death 
were: Unspecified HIV-disease (ICD-10 code B24) and tuberculosis.After non- 
specific HIV-disease, tuberculosis contributed significantly as a cause of 
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death.  No contributory causes of death as recorded in the data base were 
identified as significant contributors to mortality. 
Correlation coefficients and cause of death: 
HIV positive:        Infectious         r = 0.112  p> 0.0001  
     Non-infectious  r = -0.83  p= 0.579 
The probability of a non-infectious cause of death decreased non- significantly 
with a positive HIV status.  
HIV negative:         Infectious          r=0.083    p=0.74 
                               Non-infectious  r = 0.298   p=0.001  
HIV-negative status is significantly associated with non-infectious cause of 
death. 
HIV status and age were confounders when analysing association between 
sex and cause of death. When controlling for HIV status and age no 
association was found between sex and cause of death. 
 
 
 
   
. 
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4 LIMITATIONS 
 
The data collection relied on the medical consultants completing the data 
sheet at the time of issuing death certificates, this is done routinely every 
weekday morning, the death certificates for patients who die on weekends 
are usually completed on the following Monday.  At times death certificates 
may be completed by registrars at the request of family or the mortuary 
staff, registrars do not complete the data sheet, thus not all deaths were 
captured, the practice of registrars completing death certificates increased 
in 2009 and may be a contributing factor to the lower number of deaths 
reported in The Department of Medicine data base when compared to the 
data from Medicom. The number of medical admissions used as the 
denominator for the crude mortality rate is accurate and the high mortality 
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rate seen suggests that it is unlikely that a large number of deaths were 
excluded. The cause of death was assigned by a medical consultant and 
determined by reviewing the patient file and results, different consultants 
may have put in a varying amount of effort in trying to determine the most 
likely cause of death. Not all results such as microbiological cultures and 
histology were available at the time of completing the data sheets and the 
only outstanding results that were followed up and later entered into the 
data base were HIV and CD4 –cell count results. This may have led to an 
under- representation of diagnoses that are dependent on results of 
outstanding investigations.  
While only the primary cause of death was included in the analysis, 
consultants completing the data sheets could assign multiple causes of 
death to a single patient such as renal failure and diabetes. A principle 
components analysis using all contributing causes of death did however not 
identify any other major contributors to cause of death, analysis was thus 
restricted to the primary cause of death as assigned on the data sheet.  
 
 
 
5  STRENGTHS 
 
CHBAH was the only public inpatient health facility for the Soweto 
population during the study period. The deaths occurring at CHBAH is  thus 
representative of a large urban population in South Africa.  
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The paper-based post mortem diagnoses were determined by Internal 
Medicine consultants.  The datasheet was not an official document 
removing the limitations of Death Certificates when it came to recording HIV 
status and HIV related causes of death.  
The study period was of  a four year duration which is sufficiently long 
enough to sufficient duration to allow for the benefits of cART to be 
demonstrated if they existed. 
 
 
 
 
 
 
 
 
 
6 DISCUSSION 
 
The HIV epidemic in South Africa resulted in an increase in mortality 
and a decreased median age of death for the population. This pattern 
changed after the introduction of antiretroviral therapy to the public 
sector. Median age of death reached its nadir of 42.6 years in 2004 and 
thereafter steadily started to increase year on year and mortality 
started to decrease from 2007. This analysis from the largest hospital 
in the Southern hemisphere covers a critical time period in the 
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changing epidemiology of mortality in South Africa. The data 
presented in this study showed a significant year on year decrease in 
crude mortality in medical inpatients from 113/100000 admissions in 
2006 to 79/100000 admission in 2009. Department of Medicine 
database only captured a possible 61% of deaths in 2009 and the low 
crude mortality rate for this year may reflect missing data, however, 
when using the maximum possible number of deaths from the 
Medicom database, a significant year on year reduction in mortality 
rate from 159/100000 in 2007 to 130/100000 in 2009 is still seen. 
This decrease occurred in medical patients alone and suggests that 
the improved death rate seen at a population level is due to improved 
survival in medical patients, this may have been due to the 
introduction of cART or other changes that occurred at CHBAH during 
this time period such as the introduction of reviews of possible 
preventable causes of death and the opening of a dedicated medical 
highcare area in the admissions ward. 
 
Twenty five percent of all the ages were below 34 years, 50% of all the 
ages were below 45 years, and 75% of ages below 60 years.  
Thus, 75% of all the cases analysed were below 60 years of age, while 
25% of the cases were above 60 years.  
Half of the deceased were HIV-positive and the  results clearly indicates 
that the greatest burden of HIV deaths occurred in people younger than 40 
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years of age, the economically most active part of society with three 
quarters of deaths occurring in persons younger than 60 years. 
 
The mean age of death for the entire study population was 47.7 years, 
which is lower than the average life expectancy of South Africans in 2005. 
This is unexpected as the dataset excluded maternity and trauma-related 
deaths which occured at a younger age, this was also unexpeced as 
Soweto is an an urban population in the wealthiest province of South Africa 
with excellent access to healthcare. 
The peak age of death for females moved from the age category 30-34 
years in 2006 to 35-44 years in 2009 which is consistent with the 
changes seen at the population level. There was no change in the 
peak age category at death for males over the study period and 
probably reflects the low numbers of males within the HIV programme, 
making this an important group to target for future HIV campaigns.  
When disaggregating the data by HIV-status, mean age at death for 
HIV-positive patients showed a significant increase from 38 to 40 
years. No significant increase in the mean age for HIV-negative 
patients was seen suggesting that the increase of age at death in this 
study was likely due to interventions in the HIV-positive group of 
which the most important was the roll-out of cART. 
 
Throughout the study period HIV-positive females died at a 
significantly younger age than HIV-positive males reflecting the 
younger age of HIV-acquisition in females. In the HIV-negative group 
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females died at a significantly older age than males in 2006 and 2007, 
whilst no significant difference was observed in 2008 and 2009. The 
reversal of the normal sex-mortality pattern could not be explained 
and requires further investigation. 
Both HIV-positive males and females died at a significantly younger 
age than the HIV-negative group. An estimated 101478 years of life 
were lost due to HIV in females of this population and 65008 years of 
life were lost in HIV-positive males despite the roll-out of cART which 
was delayed in South Africa. 
Within the study being female increased the likelihood of being HIV-
positive, once again this follows the epidemiology of HIV-infection in 
sub-Saharan African. 
Of concern in this study is that over time while the proportion of 
confirmed HIV-status remained constant, there was an increase in the 
proportion of patients with an unknown HIV status, this despite a 
widespread campaign by the Department of Health to promote HIV 
counselling and testing during this period. This may be due to stigma of 
HIV-positive status with widespread public testing only gathering 
momentum after President J Zuma publically tested for HIV in April 2010. 
The  percentage of known HIV-status in the study population is however 
higher than the 30% found in KZN at this time.24  This study population 
comprised of medical inpatients and was  not a population-based cohort 
and the levels of known HIV-status are surprisingly low given the fact that 
HIV-testing could be considered an important part of the medical workup of 
a patient in Southern Africa. The decrease in HIV-testing in this study 
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population over the four year period may reflect changing patterns of 
healthcare worker testing in the inpatient population. 
 
 
 
 
 
 
 Or this may represent a group of patients unwilling to test for HIV 
both in their pre- and postmorbid state, now presenting to the 
healthcare facility with HIV-associated disease. If this trend is seen to 
continue in future analysis it requires in root cause analysis and 
appropriate interventions. 
 
When looking at the immunological status of the HIV-positive deaths 
while a large number died with CD4-counts greater than 500 cells/mm3 
the low median CD4- count of 44 cells/mm
3 shows that the majority of 
HIV-positive patients who died presented with advanced HIV-disease. 
South African Antiretroviral guidelines at the time advocated initiation of 
cART when the CD4- count was less than 200 cells/mm
3 or if the patient 
presented with an AIDS-defining illness. 
In this study the most frequently occurring CD4-count at time of death was 
less than 100 CD4 cells per cubic millimeter.  
Although when comparing the period of 2006 and 2007 with the period 
2008 and 2009, the number of cART- eligible patients on ART increased 
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significantly with only nine percent eligible patients receiving ART in 2006 
which increased to 17% by 2009 (Table 10). Patients initiated on cART are 
expected to have better survival and a sample of deaths may result in bias 
towards patients that are HIV-positive and not receiving cART. A further 
bias is that patients may have presented too ill to give a history of cART, 
the medical attendant may not have taken previous medical history and the 
patient may not have disclosed the history of antiretroviral use. 
 The data sheet did not account for timing of ART initiation, we therefore are 
unable to comment on the timing of ART initiation and subsequent  death. 
 
 
 A country’s mortality patterns reflects its developmental status, 
Population level data suggest that South Africa is in a period of 
transition with non-communicable disease-related mortality 
increasing and communicable disease-mortality decreasing. However 
due to the HIV epidemic this picture is mixed with HIV and 
tuberculosis remaining important contributors to mortality.  
 
At a population level the top two causes of death in South Africa in 2009 
were TB(12%), pneumonia(7.5%) with HIV only ranking at seventh and 
comprising 3.1% of deaths. This study showed HIV to be the number one 
cause of death at 20% followed by tuberculosis then pneumonia. The 
higher rate of HIV-deaths is probably due to underreporting at population 
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level where HIV-status is often omitted from death certificates. These 
results are closer to estimated HIV deaths.300  
Causes of death that featured prominently in this study and not at a 
population level was septicaemia, renal failure and meningitis. This may be 
due to the sicker patients being more likely to be admitted to a healthcare 
facility. Over the four year period the top three causes of death: HIV, 
tuberculosis and pneumonia did not change in neither ranking nor the 
proportion contribution to mortality. Patterns that may reflect an increased in 
population cART coverage were diarrhoea and cryptococcal meningitis 
moving out of the list of conditions contributing 75% of deaths. The only 
evidence of an increase in non-communicable disease was an increase in 
cerebrovascular disease-related deaths in this study period. While diabetes 
is a prominent disease in this population and ranked fifth at a population 
level it did not enter into the list of major contributors to mortality and was 
not identified as an underlying or secondary cause either. The reason for 
could not be ascertained. 
 
 
7 The causes of death identified in this study suggest that HIV continued to 
have a significant impact on mortality and that the population was not yet 
going through epidemiologic transition to a pattern suggesting improved 
developmental status.CONCLUSION 
 
To my knowledge, this is the largest analysis of mortality in South Africa to 
date  that has not relied on death certificates with their known inaccuracies 
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but rather used confidential  record- based post mortem analysis by medical 
consultants. 
This study showed a decrease in mortality for medical patients over the 
time period 2006-2009. Age of death increased significantly in the HIV-
positive group of patients with no change observed in the HIV-negative 
population. While infectious diseases remained the major contributors to 
death, the decrease is diseases associated with decreased immunity 
suggests that increased access to cART has impacted positively on the 
mortality patterns in this population. 
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AIDS   Acquired Immune Deficiency Syndrome  
cART   Combination Antiretroviral therapy 
CD4- count  Cluster of Differentiation Count  
CHBAH  Chris Hani Baragwanath Academic Hospital 
CMJAH  Charlotte Maxeke Johannesburg Academic Hospital 
HIV   Human Immunodeficiency Virus 
ICD-10  International Classification of Disease  
IRIS   Immune Reconstitution and Inflammatory Syndrome 
MAC   Mycobacterium Avium Complex 
WHO   World Health Organization 
NGO   Nongovernment Organisation 
p/a   Per annum 
STI   Sexually Transmitted Infection 
TB   Tuberculosis 
  
 
